BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12522212)

  • 1. Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related protein.
    Rohlena J; Kolkman JA; Boertjes RC; Mertens K; Lenting PJ
    J Biol Chem; 2003 Mar; 278(11):9394-401. PubMed ID: 12522212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein.
    Neels JG; van Den Berg BM; Mertens K; ter Maat H; Pannekoek H; van Zonneveld AJ; Lenting PJ
    Blood; 2000 Nov; 96(10):3459-65. PubMed ID: 11071642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII.
    Bovenschen N; Boertjes RC; van Stempvoort G; Voorberg J; Lenting PJ; Meijer AB; Mertens K
    J Biol Chem; 2003 Mar; 278(11):9370-7. PubMed ID: 12522143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.
    Lenting PJ; van de Loo JW; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1996 Jan; 271(4):1935-40. PubMed ID: 8567641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII.
    Kolkman JA; Mertens K
    Biochemistry; 2000 Jun; 39(25):7398-405. PubMed ID: 10858287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
    Yang X; Chang YJ; Lin SW; Walsh PN
    J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative interactions of factor IX and factor IXa with human platelets.
    Ahmad SS; Rawala-Sheikh R; Walsh PN
    J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain.
    Christophe OD; Lenting PJ; Kolkman JA; Brownlee GG; Mertens K
    J Biol Chem; 1998 Jan; 273(1):222-7. PubMed ID: 9417068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of coagulation factor VIII with members of the low-density lipoprotein receptor family follows common mechanism and involves consensus residues within the A2 binding site 484-509.
    Ananyeva NM; Makogonenko YM; Sarafanov AG; Pechik IV; Gorlatova N; Radtke KP; Shima M; Saenko EL
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):543-55. PubMed ID: 18685438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation.
    Fribourg C; Meijer AB; Mertens K
    Biochemistry; 2006 Sep; 45(35):10777-85. PubMed ID: 16939230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction.
    Kolkman JA; Christophe OD; Lenting PJ; Mertens K
    J Biol Chem; 1999 Oct; 274(41):29087-93. PubMed ID: 10506162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
    Atoda H; Yoshida N; Ishikawa M; Morita T
    Eur J Biochem; 1994 Sep; 224(2):703-8. PubMed ID: 7925387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
    Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
    Astermark J; Sottile J; Mosher DF; Stenflo J
    J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha -chains of C4b-binding protein mediate complex formation with low density lipoprotein receptor-related protein.
    Westein E; Denis CV; Bouma BN; Lenting PJ
    J Biol Chem; 2002 Jan; 277(4):2511-6. PubMed ID: 11705989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster III of low-density lipoprotein receptor-related protein 1 binds activated blood coagulation factor VIII.
    Kurasawa JH; Shestopal SA; Woodle SA; Ovanesov MV; Lee TK; Sarafanov AG
    Biochemistry; 2015 Jan; 54(2):481-9. PubMed ID: 25486042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.